Skip to main content
Erschienen in: Osteoporosis International 12/2016

04.07.2016 | Original Article

Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome

verfasst von: T. N. Hangartner, D. F. Short, T. Eldar-Geva, H. J. Hirsch, M. Tiomkin, A. Zimran, V. Gross-Tsur

Erschienen in: Osteoporosis International | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

Anthropometric adjustments of bone measurements are necessary in Prader-Willi syndrome patients to correctly assess the bone status of these patients. This enables physicians to get a more accurate diagnosis of normal versus abnormal bone, allow for early and effective intervention, and achieve better therapeutic results.

Introduction

Bone mineral density (BMD) is decreased in patients with Prader-Willi syndrome (PWS). Because of largely abnormal body height and weight, traditional BMD Z-scores may not provide accurate information in this patient group. The goal of the study was to assess a cohort of individuals with PWS and characterize the development of low bone density based on two adjustment models applied to a dataset of BMD and bone mineral content (BMC) from dual-energy X-ray absorptiometry (DXA) measurements.

Methods

Fifty-four individuals, aged 5–20 years with genetically confirmed PWS, underwent DXA scans of spine and hip. Thirty-one of them also underwent total body scans. Standard Z-scores were calculated for BMD and BMC of spine and total hip based on race, sex, and age for all patients, as well as of whole body and whole-body less head for those patients with total-body scans. Additional Z-scores were generated based on anthropometric adjustments using weight, height, and percentage body fat and a second model using only weight and height in addition to race, sex, and age.

Results

As many PWS patients have abnormal anthropometrics, addition of explanatory variables weight, height, and fat resulted in different bone classifications for many patients. Thus, 25–70 % of overweight patients, previously diagnosed as normal, were subsequently diagnosed as below normal, and 40–60 % of patients with below-normal body height changed from below normal to normal depending on bone parameter.

Conclusions

This is the first study to include anthropometric adjustments into the interpretation of BMD and BMC in children and adolescents with PWS. This enables physicians to get a more accurate diagnosis of normal versus abnormal BMD and BMC and allows for early and effective intervention.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10–26CrossRefPubMed Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10–26CrossRefPubMed
2.
Zurück zum Zitat 2 Prader-Willi Syndrome Association (USA) (2008) Osteoporosis evaluation and therapy in Prader-Willi syndrome. Consensus statement of the PWSA (USA) Clinical Advisory Board. The gathered view (ISSN 1077-9965) 94:3763–3771. 2 Prader-Willi Syndrome Association (USA) (2008) Osteoporosis evaluation and therapy in Prader-Willi syndrome. Consensus statement of the PWSA (USA) Clinical Advisory Board. The gathered view (ISSN 1077-9965) 94:3763–3771.
3.
Zurück zum Zitat Hirsch HJ, Geva-Eldar T, Benarroch F, Rubinstein O, Gross-Tsur V (2009) Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 94:2262–2268CrossRefPubMed Hirsch HJ, Geva-Eldar T, Benarroch F, Rubinstein O, Gross-Tsur V (2009) Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 94:2262–2268CrossRefPubMed
4.
Zurück zum Zitat Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, Gross-Tsur V (2010) Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol 162:377–384CrossRefPubMed Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, Gross-Tsur V (2010) Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol 162:377–384CrossRefPubMed
5.
Zurück zum Zitat Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC (2012) Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 97:E452–E459CrossRefPubMed Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC (2012) Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 97:E452–E459CrossRefPubMed
6.
Zurück zum Zitat Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A (2012) Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf) 76:72–77CrossRef Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A (2012) Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf) 76:72–77CrossRef
7.
Zurück zum Zitat Hirsch HJ, Geva-Eldar T, Benarroch F, Pollak Y, Gross-Tsur V (2015) Sexual dichotomy in gonadal function in Prader-Willi syndrome (PWS): a longitudinal study from early infancy through the fourth decade. Hum Reprod 30:2587–2596CrossRefPubMed Hirsch HJ, Geva-Eldar T, Benarroch F, Pollak Y, Gross-Tsur V (2015) Sexual dichotomy in gonadal function in Prader-Willi syndrome (PWS): a longitudinal study from early infancy through the fourth decade. Hum Reprod 30:2587–2596CrossRefPubMed
8.
Zurück zum Zitat Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID (2001) Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 103:216–222CrossRefPubMed Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID (2001) Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 103:216–222CrossRefPubMed
9.
Zurück zum Zitat Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, Richelsen B (2004) Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr 144:614–619CrossRefPubMed Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, Richelsen B (2004) Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr 144:614–619CrossRefPubMed
10.
Zurück zum Zitat Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606–613CrossRefPubMed Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606–613CrossRefPubMed
11.
Zurück zum Zitat Khare M, Gold JA, Wencel M, Billimek J, Surampalli A, Duarte B, Pontello A, Galassetti P, Cassidy S, Kimonis VE (2014) Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome. J Pediatr Endocrinol Metabol 27:511–518CrossRef Khare M, Gold JA, Wencel M, Billimek J, Surampalli A, Duarte B, Pontello A, Galassetti P, Cassidy S, Kimonis VE (2014) Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome. J Pediatr Endocrinol Metabol 27:511–518CrossRef
12.
Zurück zum Zitat Bakker NE, Kuppens RJ, Siemensma EP, van Wijngaarden RF T-de L, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Van Alfen AA, Van Leeuwen M, Van Wieringen H, Wegdam-den Boer ME, Zwaveling-Soonawala N, Hokken-Koelega AC (2015) Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. J Clin Endocrinol Metab 100:1609–1618CrossRefPubMed Bakker NE, Kuppens RJ, Siemensma EP, van Wijngaarden RF T-de L, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Van Alfen AA, Van Leeuwen M, Van Wieringen H, Wegdam-den Boer ME, Zwaveling-Soonawala N, Hokken-Koelega AC (2015) Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. J Clin Endocrinol Metab 100:1609–1618CrossRefPubMed
13.
Zurück zum Zitat Schoenau E, Frost HM (2002) The “muscle-bone unit” in children and adolescents. Calcif Tissue Int 70:405–407CrossRefPubMed Schoenau E, Frost HM (2002) The “muscle-bone unit” in children and adolescents. Calcif Tissue Int 70:405–407CrossRefPubMed
14.
Zurück zum Zitat Short DF, Gilsanz V, Kalkwarf HJ, Lappe JM, Oberfield S, Shepherd JA, Winer KK, Zemel BS, Hangartner TN (2015) Anthropometric models of bone mineral content and areal bone mineral density based on the Bone Mineral Density in Childhood Study. Osteoporos Int 26:1099–1108CrossRefPubMed Short DF, Gilsanz V, Kalkwarf HJ, Lappe JM, Oberfield S, Shepherd JA, Winer KK, Zemel BS, Hangartner TN (2015) Anthropometric models of bone mineral content and areal bone mineral density based on the Bone Mineral Density in Childhood Study. Osteoporos Int 26:1099–1108CrossRefPubMed
16.
Zurück zum Zitat De Lind van Wijngaarden RFA, Festen DAM, Otten BJ, van Mil EGAH, Rotteveel J, Odink RJ, van Leeuwen M, Haring DAJP, Bocca G, Houdijk AM, Hokken-Koelega ACS (2009) Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized clinical trial. J Clin Endocrinol Metab 94:3763–3771CrossRef De Lind van Wijngaarden RFA, Festen DAM, Otten BJ, van Mil EGAH, Rotteveel J, Odink RJ, van Leeuwen M, Haring DAJP, Bocca G, Houdijk AM, Hokken-Koelega ACS (2009) Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized clinical trial. J Clin Endocrinol Metab 94:3763–3771CrossRef
17.
Zurück zum Zitat Rubin DA, Cano-Sokoloff N, Castner DL, Judelson DA, Wright P, Duran A, Haqq AM (2013) Update on body composition and bone density in children with Prader-Willi syndrome. Horm Res Paediatr 79:271–276CrossRefPubMed Rubin DA, Cano-Sokoloff N, Castner DL, Judelson DA, Wright P, Duran A, Haqq AM (2013) Update on body composition and bone density in children with Prader-Willi syndrome. Horm Res Paediatr 79:271–276CrossRefPubMed
18.
Zurück zum Zitat Nakamura Y, Murakami N, Ilda T, Asano S, Ozeki S, Nagal T (2014) Growth hormone treatment for osteoporosis in patients with scoliosis of Prader-Willi syndrome. J Orthop Sci 19:877–882CrossRefPubMed Nakamura Y, Murakami N, Ilda T, Asano S, Ozeki S, Nagal T (2014) Growth hormone treatment for osteoporosis in patients with scoliosis of Prader-Willi syndrome. J Orthop Sci 19:877–882CrossRefPubMed
19.
Zurück zum Zitat Gordon CM, Leonard MB, Zemel BS (2014) 2013 Pediatric position development conference: executive summary and reflections. J Clin Densitom 17:219–224CrossRefPubMed Gordon CM, Leonard MB, Zemel BS (2014) 2013 Pediatric position development conference: executive summary and reflections. J Clin Densitom 17:219–224CrossRefPubMed
Metadaten
Titel
Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome
verfasst von
T. N. Hangartner
D. F. Short
T. Eldar-Geva
H. J. Hirsch
M. Tiomkin
A. Zimran
V. Gross-Tsur
Publikationsdatum
04.07.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 12/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3671-y

Weitere Artikel der Ausgabe 12/2016

Osteoporosis International 12/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.